Prof. Steinert highlights a study that he believes may prove instructive to ophthalmic surgeons trying to find the best treatment modality for their presbyopic patients.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.